-
BCAX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Bicara Therapeutics Inc. Common Stock (BCAX)
Company Profile
Quarter (USD) | Sep 24 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 520.76 mm | |||||
Cash burn (monthly) | 6.88 mm | |||||
Cash used (since last report) | 31.24 mm | |||||
Cash remaining | 489.52 mm | |||||
Runway (months of cash) | 71.2 |
13F holders | Current |
---|---|
Total holders | 72 |
Opened positions | 72 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 885.78 bn |
Total shares | 48.04 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Ra Capital Management | 6.96 mm | $177.17 bn |
Enavate Sciences GP | 3.76 mm | $69.92 mm |
Red Tree GP | 3.17 mm | $81.36 mm |
Siren, L.L.C. | 3.07 mm | $78.26 bn |
Invus Global Management | 3.04 mm | $78.04 mm |
TPG GP A | 3.01 mm | $76.68 bn |
FMR | 2.27 mm | $57.91 bn |
Omega Fund Management | 2.20 mm | $56.15 bn |
Deerfield Management | 1.80 mm | $45.72 bn |
Longitude Capital Partners IV | 1.73 mm | $32.11 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Sep 24 | Flynn James E | Common Stock | Buy | Acquire P | Yes | No | 18 | 35,000 | 630.00 k | 897,587 |
17 Sep 24 | Flynn James E | Common Stock | Buy | Acquire P | Yes | No | 18 | 35,000 | 630.00 k | 897,587 |
17 Sep 24 | Flynn James E | Common Stock | Conversion | Acquire C | Yes | No | 0 | 862,587 | 0.00 | 862,587 |
17 Sep 24 | Flynn James E | Common Stock | Conversion | Acquire C | Yes | No | 0 | 862,587 | 0.00 | 862,587 |
17 Sep 24 | Flynn James E | Series C Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 7,973,325 | 0.00 | 0 |
17 Sep 24 | Flynn James E | Series C Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 7,973,325 | 0.00 | 0 |
16 Sep 24 | Biocon | Common Stock | Conversion | Acquire C | Yes | No | 0 | 1,080,775 | 0.00 | 1,080,775 |
16 Sep 24 | Biocon | Common Stock | Conversion | Acquire C | Yes | No | 0 | 4,327,365 | 0.00 | 4,443,122 |
16 Sep 24 | Biocon | Series Seed Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 9,990,144 | 0.00 | 0 |
16 Sep 24 | Biocon | Series Seed Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 40,000,000 | 0.00 | 0 |